SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly is experiencing extreme volatility and a sharp sell-off following its recent quarterly financial results, with the community actively debating whether the decline is an overreaction to record-breaking revenue or a necessary market correction. Many investors are currently focused on whether this drawdown presents a buying opportunity, while others remain skeptical and caution against catching a falling knife.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently the center of intense investor focus as the community anticipates strong Q1 earnings and potential updates regarding the Neutron rocket, hypersonic defense contracts, and strategic acquisitions like Mynaric. Traders are closely monitoring these developments alongside broader sector rotation, with many viewing current price fluctuations as a consolidation phase before a potential rally fueled by the company's expanding backlog and pivotal role in U.S. national security infrastructure.

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

Atara Biotherapeutics Inc

Atara Biotherapeutics is trending as investors react to a significant regulatory update regarding tabelecleucel, with community discourse divided between optimism over the path to FDA approval and skepticism regarding the company's financial stability and dilution risks. Traders are closely monitoring the stock's volatility and institutional activity, while debating whether the current price action reflects a true recovery or potential downside volatility.

TSS, Inc. engages in the provision of comprehensive services for the planning, design, development and maintenance of mission-critical facilities and information infrastructure as well as integration services. It operates through the Facilities and Systems Integration Services business segments. The Facilities segment consists of the design, project management, and maintenance of data center and mission-critical business operations. The Systems Integration segment integrates information technology equipment for original equipment manufacturer vendors and customers to be used inside data center environments, including modular data centers. The company was founded by Gerard J. Gallagher on December 20, 2004 and is headquartered in Georgetown, TX.

TSS Inc

TSS Inc. is trending as investors react to strong quarterly earnings that showcased significant revenue growth and profitability, though the stock has faced volatile trading and sell-off pressure. Community discourse remains divided between long-term bulls highlighting the company's strategic integration partnership with Dell and skeptics concerned about the lack of specific revenue guidance and potential short-term price manipulation.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is attracting significant community attention as traders anticipate a pivotal regulatory decision regarding the sBLA filing for Anktiva, while monitoring recent earnings performance and international expansion efforts. The broader discussion is dominated by debates over non-cash accounting adjustments in the latest financial report and expectations for upcoming clinical data presentations.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy is experiencing significant volatility as investors weigh strong revenue growth and a record backlog against concerns regarding tightening profit margins and ongoing cash flow challenges. The community is actively debating the company's position as a key infrastructure provider for AI data centers versus its persistent struggle to achieve consistent bottom-line profitability.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is currently trending as investors debate the sustainability of the AI infrastructure cycle following reports of an $18 billion financing hurdle for an OpenAI custom chip project. While the market digests potential risks to hyperscaler capital commitments, the community remains divided between those viewing the pullback as a valuation reset within a persistent expansion cycle and those concerned about potential bubbles in AI compute demand.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is trending as investors weigh strong profitability and recent AAA-rated bond successes against broader geopolitical tensions and volatility in the fintech sector. While the community is actively debating the company's valuation gap compared to peers, sentiment remains divided between those expecting a potential short squeeze around upcoming earnings and skeptics focused on institutional insider selling.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is experiencing extreme market volatility as investors weigh strong AI-driven demand and long-term revenue potential against supply chain constraints and a stretched valuation. While the community remains deeply divided between long-term bulls betting on the company's role as the architectural backbone of AGI and skeptics warning of a speculative bubble, price action continues to be driven by aggressive rotation and institutional profit-taking following recent earnings.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors weigh strong earnings performance and expanded Matrix-M partnerships against concerns over executive compensation and a lack of clear monetization for key pipeline assets. Community discussion is heavily focused on the potential impact of an activist investor's upcoming proxy campaign and the broader market implications of the company's shift toward oncology and infectious disease licensing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Raphael Pharmaceutical, Inc. is a clinical-stage biotechnology company. It is focused on providing a novel cannabinoid-based research platform for the treatment of inflammatory diseases. The firm’s product candidate, HPC1, is a cannabinoid formulation developed for the treatment of rheumatoid arthritis. The company was founded in May 2007 and is headquartered in Tel Aviv, Israel.

RAPH
Raphael Pharmaceutical Inc

Feed

News

Sentiment

Fundamentals

Info

Latest RAPH News

RAPHRaphael Pharmaceutical Inc